Epidemiology of Psoriasis in Germany - Analysis of Secondary Health Insurance Data

被引:62
|
作者
Schaefer, I. [1 ]
Rustenbach, S. J. [1 ]
Radtke, M. [1 ]
Augustin, J. [1 ]
Glaeske, G. [2 ]
Augustin, M. [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, CVderm Competenzzentrum Versorgungsforsch Dermato, Klin & Poliklin Dermatol & Venerol, D-20246 Hamburg, Germany
[2] Univ Bremen, Zentrum Sozialpolit, D-2800 Bremen 33, Germany
关键词
psoriasis; prevalence; epidemiology; secondary data; CLINICAL-FEATURES; PREVALENCE; ARTHRITIS; QUALITY; POPULATION;
D O I
10.1055/s-0030-1252022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: In Germany, population-based data on the epidemiology of psoriasis are still rare. This study aims to assess the prevalence of psoriasis in the total population as well as for subgroups relevant to health care. As further epidemiological parameters the severity and regional distribution of psoriasis were analysed. Methods: A secondary analysis of data collected routinely for the members of a nationwide statutory health insurance company was conducted. Prevalences were calculated for a closed cohort of continuously insured persons in 2005. Defined criteria for the existence of psoriasis were at least one diagnoses of psoriasis (ICD-10) relating to ambulatory or hospital treatment or disability. Results: 33 981 of the 1 344 071 continuously insured persons in 2005 were diagnosed with psoriasis, thus the one-year-prevalence in this cohort was 2.53 %. Up to the age of 80 years the prevalence rate was increasing with increasing age and highest for the age groups from 50 to 79 years (range: 3.99-4.18 %). Insured persons up to 20 years had a prevalence of 0.73 %. Regional differences showed up after stratification for broad categories (1 digit) of ZIP codes: Lowest prevalence rates were seen in the south (2.17 %) and highest (2.78 %) in the north and western regions of Germany. Conclusions: If the prevalence rate of 2.5 % assessed in this study is applied to the total resident population, 2 million people are treated because of psoriasis in Germany. Routine data from health insurance companies are a relevant and suitable data source to assess the prevalence of chronic diseases (under medical treatment) in the population.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 50 条
  • [21] Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance
    Kienitz, Carsten
    Grellmann, Claudia
    Hapfelmeier, Jana
    [J]. GESUNDHEITSWESEN, 2021, 83 (05) : 367 - 373
  • [22] Sickle Cell Disease in Newborns in Germany: Analysis of the AOK Health Insurance Data
    Pattloch, Dagmar
    [J]. GESUNDHEITSWESEN, 2019, 81 (12) : 986 - 992
  • [23] Who is treated, and how, for depression?An analysis of statutory health insurance data in Germany
    Anke Bramesfeld
    Thomas Grobe
    Friedrich Wilhelm Schwartz
    [J]. Social Psychiatry and Psychiatric Epidemiology, 2007, 42 : 740 - 746
  • [24] Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany
    Bramesfeld, Anke
    Grobe, Thomas
    Schwartz, Friedrich Wilhelm
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2007, 42 (09) : 740 - 746
  • [25] Epidemiology of Scabies in Germany: Multi-Source Analysis of Primary- and Secondary Data
    Kirsten, N.
    Garbe, C.
    Girbig, G.
    Stroemer, K.
    Augustin, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 44 - 45
  • [26] Secondary Data Analysis of Epidemiology in Asia
    Murakami, Yoshitaka
    [J]. JOURNAL OF EPIDEMIOLOGY, 2014, 24 (05) : 345 - 346
  • [27] Epidemiology of multiple sclerosis in Germany. Regional differences and drug prescription in the claims data of the statutory health insurance
    Petersen, G.
    Wittmann, R.
    Arndt, V.
    Goepffarth, D.
    [J]. NERVENARZT, 2014, 85 (08): : 990 - 998
  • [28] Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019
    Akmatov, Manas K.
    Holstiege, Jakob
    Dammertz, Lotte
    Heuer, Joachim
    Kohring, Claudia
    Lotto-Batista, Martin
    Boeing, Friedrich
    Ghozzi, Stephane
    Castell, Stefanie
    Baetzing, Joerg
    [J]. EUROSURVEILLANCE, 2022, 27 (32)
  • [29] EPIDEMIOLOGY OF HEMOPHILIA IN GERMANY: RESULTS FROM A GERMAN STATUTORY HEALTH INSURANCE CLAIMS DATABASE-ANALYSIS
    Eichler, H.
    Langer, F.
    Koscielny, J.
    Beier, D.
    Schmedt, N.
    Haeckl, D.
    Horneff, R.
    Hohmann, D.
    [J]. VALUE IN HEALTH, 2019, 22 : S852 - S852
  • [30] Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002-2018
    Jang, Albert Youngwoo
    Lee, Hyeok-Hee
    Lee, Hokyou
    Kim, Hyeon Chang
    Chung, Wook-Jin
    [J]. KOREAN CIRCULATION JOURNAL, 2023, 53 (05) : 313 - 327